Skip to main navigation Skip to search Skip to main content

Research on Cholangiocarcinoma Described by Researchers at First Affiliated Hospital of Dalian Medical University (Case report of acute hepatorenal failure induced by third-line treatment with tislelizumab in a patient with cholangiocarcinoma: ...)

Press/Media: Research

PeriodDec 30 2025

Media coverage

1

Media coverage

  • TitleResearch on Cholangiocarcinoma Described by Researchers at First Affiliated Hospital of Dalian Medical University (Case report of acute hepatorenal failure induced by third-line treatment with tislelizumab in a patient with cholangiocarcinoma: ...)
    Media name/outletGastroenterology Daily News
    Country/TerritoryUnited States
    Date12/30/25
    PersonsBin Zhang